https://pharmadevicenews.com/newamsterdam-pharma-and-menarini-win-eu-approval-for-ubeslo-and-evlarco/ PharmaDeviceNews en 2026-09-30T06:39:58+00:00 NewAmsterdam Pharma and Menarini win EU approval for Ubeslo and Evlarco BROADWAY, BROOKLYN, European Commission, European Medicines Agency, Evlarco, Menarini Group, NewAmsterdam Pharma Company N.V., obicetrapib, PREVAIL, Tandem, Ubeslo https://pharmadevicenews.com/wp-content/uploads/2026/09/ChatGPT-Image-Sep-30-2026-12_07_59-PM-e1790750652959.webp https://pharmadevicenews.com/amt-130-four-year-data-extend-huntingtons-disease-signal-as-fda-evaluates-uniqure-bla/ PharmaDeviceNews en 2026-09-29T19:44:19+00:00 AMT-130 four-year data extend Huntington’s disease signal as FDA evaluates uniQure BLA ifezuntirgene inilparvovec, uniQure, United States Food and Drug Administration https://pharmadevicenews.com/wp-content/uploads/2026/09/Brain-imaging-e1790710756334.webp https://pharmadevicenews.com/novo-nordisk-bets-up-to-2-6bn-on-hengruis-once-weekly-oral-glp-1-gip-drug/ PharmaDeviceNews en 2026-09-29T18:38:09+00:00 Novo Nordisk bets up to $2.6bn on Hengrui’s once-weekly oral GLP-1/GIP drug Hengrui Pharma, HRS-1596, Novo Nordisk https://pharmadevicenews.com/wp-content/uploads/2026/09/Oral-metabolic-drug-research-e1790707052160.webp https://pharmadevicenews.com/evorpacept-biomarker-signal-deepens-in-her2-positive-gastric-cancer-as-alx-oncology-shifts-focus/ PharmaDeviceNews en 2026-09-28T22:19:56+00:00 Evorpacept biomarker signal deepens in HER2-positive gastric cancer as ALX Oncology shifts focus ALX Oncology, evorpacept, HER2, Nature Medicine https://pharmadevicenews.com/wp-content/uploads/2026/09/Gastric-cancer-imaging-e1790632883220.webp https://pharmadevicenews.com/teva-wins-fda-approval-for-degevma-biosimilar-across-all-xgeva-indications/ PharmaDeviceNews en 2026-09-28T20:53:58+00:00 Teva wins FDA approval for DEGEVMA biosimilar across all Xgeva indications Amgen, DEGEVMA, Teva Pharmaceutical Industries, XGEVA https://pharmadevicenews.com/wp-content/uploads/2026/09/Study-of-cancer-related-bone-disease-e1790628511988.webp